APELLIS PHARMACEUTICALS INC (APLS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APLS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APLS | Independent Director | 63 | ["Executive-in-Residence, Canaan Partners, a venture capital firm dedicated to early stage investing in health care and technology (2019 \u2013 present)", "Held number of senior executive roles, Boehringer Ingelheim", "Chairman, Boehringer Ingelheim USA (2018 \u2013 2019)", "President and Chief Executive Officer, Boehringer Ingelheim USA (2011 \u2013 2018)", "President, Boehringer Ingelheim Animal Health USA (2018 \u2013 2019)", "Corporate Senior Vice President, Prescription Medicines Marketing, Boehringer Ingelheim GmbH (2009 \u2013 2011)", "Joined 2004", "Held commercial leadership roles, Merck and Co. Inc. (1995 \u2013 2004)", "Held commercial leadership roles, Abbott Laboratories (1987 \u2013 1995)"] | ["Audit", "Compensation", "Compliance"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMLX | Director | 63 | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Independent Director since 2020 Age: 63 Committees: Audit Compensation Compliance (Chair) Experience Executive-in-Residence, Canaan Partners, a venture capital firm dedicated to early stage investing in health care and technology (2019 present) Held number of senior executive roles, Boehringer Ingelheim; Chairman, Boehringer Ingelheim USA (2018 2019); President and Chief Executive Officer, Boehringer Ingelheim USA (2011 2018); President, Boehringer Ingelheim Animal Health USA (2018 2019); Corporate Senior Vice President, Prescription Medicines Marketing, Boehringer Ingelheim GmbH (2009 2011); joined 2004 Held commercial leadership roles, Merck and Co. Inc. (1995 2004) Held commercial leadership roles, Abbott Laboratories (1987 1995) Qualifications Extensive experience leading large commercial organizations in the pharmaceutical industry Significant sales and marketing management experience Education M.B.A., Carnegie Mellon University M.S., Chemical Engineering, University of Brussels (Belgium) Other Boards Amylyx Pharmaceuticals, Inc. (2021 present) Apnimed Pharmaceuticals, Inc. (private, 2023 present) Corium Therapeutics, Inc. (private, 2023 present) Covetrus Inc. (2021 2022) Ypsomed AG (2018 present) Gelesis, Inc. (2018 2023) DalCor Pharmaceuticals (private, 2019 present) AMAG Pharmaceuticals, Inc. (2019 2020) ResTORbio, Inc. (2017 2020) PhRMA, the industry association for the pharmaceutical industry (formerly)